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The NDP-sugar co-substrate concentration and the enzyme
expression level in£uence the substrate speci¢city of
glycosyltransferases: cloning and characterization of
deoxysugar biosynthetic genes of the urdamycin biosynthetic
gene cluster
D Hoffmeister 1, *, K Ichinose, 2;*, S Domann 1;3, B Faust 1, A Trefzer 1,
G Dra« ger 3, A Kirschning 3, C Fischer 4, E Ku« nzel 4, DW Bearden 5, J Rohr 4
and A Bechthold 1
Background: Streptomyces fradiae is the principal producer of urdamycin A. The
antibiotic consists of a polyketide-derived aglycone, which is glycosylated with
four sugar components, 2U D-olivose (¢rst and last sugar of a C-glycosidically
bound trisaccharide chain at the 9-position), and 2U L-rhodinose (in the middle of
the trisaccharide chain and at the 12b-position). Limited information is available
about both the biosynthesis of D-olivose and L-rhodinose and the in£uence of the
concentration of both sugars on urdamycin biosynthesis.
Results: To further investigate urdamycin biosynthesis, a 5.4 kb section of the
urdamycin biosynthetic gene cluster was sequenced. Five new open reading
frames (ORFs) (urdZ3, urdQ, urdR, urdS, urdT) could be identi¢ed each one
showing signi¢cant homology to deoxysugar biosynthetic genes. We inactivated
four of these newly allocated ORFs (urdZ3, urdQ, urdR, urdS) as well as urdZ1, a
previously found putative deoxysugar biosynthetic gene. Inactivation of urdZ3,
urdQ and urdZ1 prevented the mutant strains from producing L-rhodinose
resulting in the accumulation of mainly urdamycinone B. Inactivation of urdR led
to the formation of the novel urdamycin M, which carries a C-glycosidically
attached D-rhodinose at the 9-position. The novel urdamycins N and O were
detected after overexpression of urdGT1c in two different chromosomal urdGT1c
deletion mutants. The mutants lacking urdS and urdQ accumulated various
known diketopiperazines.
Conclusions: Analysis of deoxysugar biosynthetic genes of the urdamycin
biosynthetic gene cluster revealed a widely common biosynthetic pathway leading
to D-olivose and L-rhodinose. Several enzymes responsible for speci¢c steps of
this pathway could be assigned. The pathway had to be modi¢ed compared to
earlier suggestions. Two glycosyltransferases normally involved in the
C-glycosyltransfer of D-olivose at the 9-position (UrdGT2) and in conversion of
100-2 to urdamycin G (UrdGT1c) show relaxed substrate speci¢city for their
activated deoxysugar co-substrate and their alcohol substrate, respectively. They
can transfer activated D-rhodinose (instead of D-olivose) to the 9-position, and
attach L-rhodinose to the 4A-position normally occupied by a D-olivose unit,
respectively.
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Introduction
Urdamycin A (Figure 1A), produced by Streptomyces fradiae
Tu« 2717, is an antibiotic and anticancer agent [1]. It consists
of an angucyclic polyketide core and four deoxyhexoses:
two L-rhodinoses and two D-olivoses. Urdamycin polyke-
tide formation as well as tailoring reactions and glycosyl-
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transfer are genetically well understood. A type II polyke-
tide synthase (PKS) is responsible for decaketide synthesis.
After cyclization and reduction, a C-glycosidic D-olivose
transfer at position 9 of the polyketide core is performed
by the glycosyltransferase UrdGT2 [2,3]. The later glyco-
sylation steps include a L-rhodinose transfer to position C-
12b, and an attachment of L-rhodinose and D-olivose to
complete the trisaccharide side chain at C-9 [4]. As no
urdamycin derivative with variation in the order of the
sugar moieties has ever been found, a high speci¢city of
the glycosyltransferases towards the sugar substrates has
been concluded [4]. The biosynthetic pathway to NDP-
D-olivose and NDP-L-rhodinose in S. fradiae has never
been explored in detail. Early genetic work on the urda-
mycin biosynthetic gene cluster revealed the presence of a
NDP-glucose synthase gene (urdG) and a NDP-glucose-
4,6-dehydratase gene (urdH). Therefore we expected the
early steps of deoxysugar formation to be essentially the
same as found for D-desosamine and L-mycarose produc-
tion in the erythromycin producer [5^7], D-olivose, D-oliose
and D-mycarose formation in the mithramycin producer [8]
or D-daunosamine synthesis in the daunomycin producer
[9], which is the conversion of glucose-1-phosphate to
NDP-glucose and further conversion to NDP-4-keto-6-de-
oxy-D-glucose.
4-Keto-6-deoxy-D-glucose has been discussed to be the
key intermediate in the biosynthesis of many different
deoxysugars [10]. In strains producing different deoxysu-
gars, independent pathways from 4-keto-6-deoxyglucose to
each sugar have been found [11]. In this work we cloned,
sequenced and characterized further deoxysugar biosyn-
thetic genes of the urdamycin cluster, and investigated
whether the substrate speci¢city of glycosyltransferases
can be modi¢ed.
Results
Cloning and sequencing of a 5.4 kb section of the
urdamycin cluster
A 5.4 kb section of the urdamycin biosynthetic gene clus-
ter located downstream of urdH was sequenced (Figure 2).
Computer-based sequence analysis showed that it harbors
¢ve new open reading frames (ORFs) (urdZ3, urdQ, urdR,
urdS, and partially urdT). Throughout this region we found
an average G/C content of 68.7% which is typical for Strep-
tomyces DNA, and third codon positions were signi¢cantly
biased towards G and C. Upstream of all genes putative
ribosome binding sites similar to the consensus sequence
published by Strohl [12] were detected.
Database comparison of UrdZ3, a 346 amino acid (aa) pro-
tein, revealed close similarity to proteins of different origin
which act as (or presumably are) NDP-hexose 4-ketoreduc-
tases, highest homology is found to LanZ3 (accession num-
ber: AF080235), a NDP-hexose 4-ketoreductase homolog
from the landomycin producer Streptomyces cyanogenus S 136
(42% identical aa) [13]. The deduced protein of urdQ has
434 aa (molecular weight 48.081 kDa) and shows highest
similarity to LanQ (AF080235), a NDP-hexose 3,4-dehy-
dratase homolog from S. cyanogenus S 136 (85% identical aa)
[13], to GraOrf23 (AJ011500), a putative dTDP-4-keto-6-
deoxyglucose 3-dehydratase of the granaticin producer
S. violaceoruber Tu« 22 (70% identical aa) [14], and to a
NDP-hexose 3-dehydratase from Amycolatopsis mediterranei
[15] (71% identical aa). urdR encodes a 247 aa protein with
26.837 kDa molecular weight. It most resembles LanR, a
NDP-hexose 4-ketoreductase homolog from S. cyanogenus
(69% identical aa) [13], and an unnamed protein of Actino-
bacillus actinomycetemcomitans (27% identical aa) [16]. UrdR,
like the other proteins, contains the NAD cofactor bind-
ing motif YxxxKxxxD/E which is conserved in numerous
putative 4-ketoreductases. The urdS reading frame should
yield a 469 aa protein of 52.112 kDa molecular weight. It
closely resembles proteins identi¢ed as NDP-hexose 2,3-
dehydratases in various species. Highest homology (75%
identical aa) is found to LanS [13], a NDP-hexose 2,3-
dehydratase homolog of S. cyanogenus, to a putative 2,3-
dehydratase (ORF23) of the chloroeremomycin producer
Amycolatopsis orientalis (68% identical aa) [17] and to AveB-
VI, a TDP-4-keto-6-deoxy-L-hexose 2,3-dehydratase of S.
avermitilis (64% identical aa) [18]. Downstream of urdS we
found an incomplete ORF named urdT. Homology of the
deduced 269 amino acids gene product suggests that urdT
encodes an oxidoreductase, since throughout the cloned
and sequenced part signi¢cant similarity is found to the
product of lanT, an oxidoreductase homolog of S. cyanoge-
nus (58% identical aa) [13], to an oxidoreductase from A.
mediterranei (53% identical aa) [15], and to GraOrf26 of
S. violaceoruber [14].
Inactivation of deoxysugar biosynthetic genes
For inactivation of urdQ, urdR, urdS, urdZ1 and urdZ3,
plasmids were constructed allowing the replacement of
the wild-type (wt) gene by a mutated allele.
A mutant lacking urdS does not accumulate any
urdamycin derivative but accumulates
cyclo-(alanyl-4-hydroxyprolyl)
To determine the function of urdS, mutants were gener-
6
Figure 1. (A) Selected structures of compounds produced by S. fradiae Tuë2717 and mutants generated during this study. (B) Structures of
diketopiperazines produced by mutants generated during this study.
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ated using plasmid pKurdSpm which contains a frameshift
mutation within urdS due to the alteration of a NcoI re-
striction site. After S. fradiae protoplasts were transformed
with plasmid pKurdSpm, apramycin-resistant colonies were
obtained. The transformation ef¢ciency was about 100 col-
onies per Wg DNA. Numerous colonies were grown on
plates containing no apramycin to select for loss of resis-
tance. Eight apramycin-sensitive colonies were obtained
suggesting that they were the consequence of a double
cross-over. Mutant urdSpm was further examined. PCR
fragments, obtained from urdSpm using primers S-1 and
S-2, could be digested by PstI and DraIII, but not by NcoI,
whereas PCR fragments obtained from the wt strain could
be digested by all three enzymes. Analysis of the culture
supernatant of urdSpm showed that it did not accumulate
any urdamycin derivative. A compound accumulated in-
stead was determined to be cyclo-(alanyl-4-hydroxyprolyl)
(Figure 1B).
Mutants lacking either urdQ, urdZ1, or urdZ3
predominantly accumulate urdamycinone B
To inactivate urdQ, urdZ1, and urdZ3, gene inactivation
plasmids pKurdQifD and pKurdQpm (inactivation of
urdQ), pKC-urdZ1d (inactivation of urdZ1) and pKC-
urdZ3d (inactivation of urdZ3) were constructed. S. fradiae
Tu« 2717 protoplasts were transformed with these plasmids.
About 80 apramycin-resistant colonies per Wg DNA for
each urdQ inactivation construct and approximately 150
per Wg DNA for pKC-urdZ1d and pKC-urdZ3d were ob-
tained. Some of each were further cultivated screening for
loss of apramycin resistance. Mutants urdQifD, urdQpm
(both lacking urdQ), BF-3-1 (lacking urdZ1), and Z3-148
(lacking urdZ3) were chosen for further investigation. The
size of PCR fragments obtained from urdQifD with prim-
ers Q-1 and Q-2 was 0.9 kb while the wt strain gave a PCR
fragment of the expected lower mobility (1.23 kb). To
con¢rm the presence of the deletion within urdQ Southern
blot analysis was performed as follows. When PstI-digested
chromosomal DNA prepared from urdQifD was probed
with a 2.3 kb PstI fragment (fragment c in Figure 2) a
1.97 kb fragment was detected while the expected 2.3 kb
fragment could be identi¢ed in the S. fradiae wt strain.
There was no hybridization signal when an internal
0.7 kb SacI fragment of pKC1132 was used. These results
con¢rmed the presence of the expected deletion. PCR
fragments obtained from mutants urdQpm (primers Q-1
and Q-2), BF-3-1 (primers Z1-1 and Z1-2) and Z3-148
(primers Z3-1 and Z3-2) were analyzed by restriction anal-
ysis. Fragments could not be restricted by NcoI (urdQpm),
SalI (BF-3-1) and MroI (Z3-148) which were the endonu-
cleases employed for frameshifting. In contrast, PCR prod-
ucts ampli¢ed with wt DNA as template were digestible in
each case. Secondary metabolites of all mutants were pre-
dominantly urdamycinone B (Figure 1A). Aquayamycin
(Figure 1A) was also detectable in mutant Z3-148, and
mutant urdQpm also accumulated cyclo-(leucyl-4-hydroxy-
prolyl) and cyclo-(phenylalanyl-4-hydroxyprolyl) (Figure
1B).
Figure 2. Genetic organization of the urdamycin biosynthetic gene cluster. Genes are indicated by arrows oriented in the direction of
transcription. Genes encoding glycosyltransferases are red, PKS genes are blue. Genes encoding enzymes involved in deoxysugar
biosynthesis are green. Fragments a^d have been used in constructing plasmids for gene disruption and gene expression experiments.
(P, PstI; Sa, SalI; M, MroI; N, NcoI; Sp, SplI).
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A mutant lacking urdR accumulates the new urdamycin M
A chromosomal mutant of urdR was created by transform-
ing S. fradiae Tu« 2717 with plasmid pKCRN resulting in
approximately 200 apramycin-resistant colonies per Wg
DNA. After screening for double cross-over the apramy-
cin-sensitive strain RN-435 was obtained. PCR fragments
obtained from RN-435 using primers R-1 and R-2 could
not be digested by SplI, while PCR fragments obtained
from the wt strain were restrictable by this enzyme. The
analysis of culture supernatants of mutant RN-435 showed
that one new compound, urdamycin M (Figure 1A), along
with rabelomycin, urdamycins I and J (Figure 1A) and
several urdamycin derivatives not yet identi¢ed, were pro-
duced instead of urdamycin A.
Complementation of urdSpm, urdQifD, urdQpm, BF-3-1,
Z3-148, and RN-435
To determine clearly that the mutation event only affected
the desired genes and no other genes, urdQ, urdR, urdS,
urdZ1, and urdZ3 were cloned into pUWL201 [4] or pEM4
[20] and introduced by protoplast transformation into the
corresponding mutants. In each case urdamycin A produc-
tion was restored. Thus, we could rule out any upstream or
downstream effects.
Expression of urdGT1a, urdGT1b, urdGT1c and urdGT2 in
mutant Ax and mutant 16-14
Expression of urdGT1c in mutant Ax, in which three gly-
cosyltransferase genes had been deleted before, resulted in
the formation of 12b-derhodinosyl-urdamycin G as the
main product [4]. This experiment allowed the unambig-
uous functional assignment of UrdGT1c as a glycosyltrans-
ferase catalyzing the transfer of NDP-L-rhodinose to the
¢rst sugar of the trisaccharide side chain during urdamycin
A biosynthesis. Further in-depth analysis of this strain, in
which urdGT1c was overexpressed, revealed a new, previ-
ously unidenti¢ed compound. We now determined the
structure of this new urdamycin derivative, urdamycin N
(Figure 1A), which is not detectable in the wt strain. Ur-
damycin N contains an additional L-rhodinose moiety at-
tached to the second sugar of the side chain of compound
100-1, an intermediate of the branch pathway leading to
urdamycin B [4,19]. Thus, urdamycin N is a urdamycin B
analog with a L-rhodinose instead of a D-olivose as terminal
sugar of the C-glycosidically bound trisaccharide chain. In
contrast, Ax mutants complemented with either urdGT1a,
urdGT1b or urdGT2 did not produce any other urdamycin
derivative than the one described by Trefzer et al. [4].
To rule out any incidental effects on urdamycin biosynthe-
sis we also reinvestigated the urdamycin spectrum after
expression of urdGT1c in mutant 16-14 [4], which is defec-
tive for both urdGT1b and urdGT1c but carries instead a
chromosomal hybrid thereof. Analysis of the culture super-
natant revealed the presence of a hitherto unknown urda-
mycin derivative, urdamycin O. It arises from an attach-
ment of another L-rhodinose to the second sugar of the
C-glycosidically linked side chain of urdamycin G (Figure
1A), and thus is an urdamycin A analog with a terminal K-
L-rhodinose instead of a L-D-olivose in the trisaccharide
chain.
Discussion
The biosynthesis of the angucycline antibiotic urdamycin
A is a multi-step process in which the elaboration of the
polyketide chain is followed by a number of steps includ-
ing speci¢c hydroxylation and glycosylation. Single sugar
residues of urdamycin A are D-olivose and L-rhodinose.
Previous work demonstrated that urdGT1a, urdGT1b,
urdGT1c, and urdGT2 encode glycosyltransferases each re-
sponsible for a certain biosynthetic saccharide attachment
step during urdamycin biosynthesis. Our work now was
aimed at identifying and elucidating the function of genes
involved in the biosynthesis of NDP-D-olivose and NDP-
L-rhodinose. Analysis of a 5.4 kb fragment identi¢ed sev-
eral putative deoxysugar biosynthetic genes. Based on the
sequencing data the biosynthetic pathways from glucose-1-
phosphate to NDP-D-olivose and NDP-L-rhodinose togeth-
er should comprise eight steps. This would include NDP-
D-glucose synthesis [21] (UrdG), a 4,6-dehydratation [22]
(UrdH), a 2,3-dehydratation (UrdS) and a reduction (UrdT)
[23] to yield NDP-4-keto-2,6-dideoxy-D-glucose. The re-
maining four steps would be a 4-ketoreduction (UrdR) to
prepare NDP-D-olivose and a pyridoxamine-catalyzed de-
hydration [24] (UrdQ) followed by a 5-epimerization
(UrdZ1) and a 4-ketoreduction (UrdZ3) to prepare NDP-
L-rhodinose (Figure 3). Targeted inactivation of urdQ,
urdR, urdS, urdZ1, and urdZ3 was accomplished during
this study. Analysis of compounds produced by the mu-
tants provided unequivocal evidence that urdQ, urdZ1, and
urdZ3 are involved in NDP-L-rhodinose biosynthesis, since
strains lacking such genes accumulated urdamycinone B
(Figure 1A), as expected if they are speci¢cally defective
in the synthesis of NDP-L-rhodinose. However, further
biochemical studies are necessary to con¢rm our functional
assignment of urdQ, urdZ1, and urdZ3.
urdR has been shown to be the gene speci¢cally required
for NDP-D-olivose formation, as the urdR mutant accumu-
lates urdamycin M. This novel urdamycin exclusively con-
tains rhodinose moieties and lacks any D-olivose. Therefore
it must be a single-step process to convert the central
intermediate NDP-4-keto-2,6-dideoxy-D-glucose to D-oli-
vose. The D-rhodinose moiety in urdamycin M also reveals
that the 3-deoxygenation occurs prior to the 5-epimeriza-
tion (DCL switch), as was recently suggested for landomy-
cin biosynthesis [25]. Interestingly, the 4-ketoreductase
UrdZ3 seems to be able to reduce NDP-D-cinerulose as
well as NDP-L-cinerulose (Figure 3). Anyway, UrdZ3
might act speci¢cally on the D-sugar but then reduction
by UrdZ3 must occur prior to epimerization by UrdZ1.
Deletion of urdS was accomplished by introducing a frame-
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shift mutation into the gene resulting in the formation of a
fusion protein UrdS^UrdT. Surprisingly, no urdamycin de-
rivative was detectable in this mutant urdSpm. Similar to
the urdQifD and urdQpm mutants urdSpm accumulates
diketopiperazines, which are normally not detected in the
wt strain. In total, the structures of three different diketo-
piperazines were determined: cyclo-(phenylalanyl-4-hy-
droxyprolyl), cyclo-(leucyl-4-hydroxyprolyl), and cyclo-(ala-
nyl-4-hydroxyprolyl). They have been described before as
natural products isolated from a Jaspidae sponge [26], from
rabbit [27], or as a product made by combinatorial chem-
istry [28]. The accumulation of these cyclic dipeptides in
the urdamycin mutants might represent an example for the
onset of another biosynthetic pathway if the biosynthesis
of the main product is blocked. At this stage, we cannot
explain why mutant urdSpm does not produce any non-
glycosylated urdamycin derivative. A similar result has
been observed by Fish and Cundliffe [29]: the targeted
disruption of tylM2, a glycosyltransferase from the tylosin
producer S. fradiae abolished the biosynthesis of the agly-
cone tylactone because of an intricate regulatory feedback
mechanism in the producer strain.
The accumulation of urdamycin M in the urdR mutant not
only indicates the putative function of urdR, but also shows
that UrdGT2, which was identi¢ed to catalyze the C-gly-
cosylation of NDP-D-olivose in the wt strain, now accepts
NDP-D-rhodinose as the sugar co-substrate. This differs
from the normal sugar co-substrate in that it has a deoxy-
genated 3-position and an inverted stereochemistry at the
4-position. As not even traces of urdamycin M can be
found in the wt strain, we postulate that the function of
UrdGT2 is controlled by several parameters. Beside ki-
netic parameters (KM, Vmax) some kind of channeling of
the sugar substrates towards the glycosyltransferase and
the formation of enzyme complexes by the deoxysugar
forming enzymes and the glycosyltransferases might help
to explain the accumulation of the new urdamycin deriva-
tives.
Recently, we described the generation of glycosyltransfer-
ase mutants (mutant Ax, mutant 16-14) of the urdamycin
producer, in which three (Ax) or two (16-14) of the glyco-
syltransferase encoding genes had been deleted [4]. These
mutants were then used as hosts for expressing single gly-
cosyltransferase genes of the cluster, which had been de-
leted before. The experiment supported the assignment of
each glycosyltransferase of the urdamycin cluster to a cer-
tain biosynthetic saccharide attachment step. We now re-
investigated various extracts of the Ax mutant, which was
complemented with either urdGT1a, urdGT1b or urdGT1c,
and extracts of 16-14 complemented with urdGT1c. While
we could not ¢nd new urdamycin derivatives in extracts of
mutant Ax complemented with either urdGT1a or
urdGT1b, a new derivative (urdamycin N) was detected
in the Ax mutant complemented with urdGT1c. Analo-
Figure 3. Biosynthetic pathway to NDP-D-
olivose and NDP-L-rhodinose in S. fradiae
Tuë2717.
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gously, the novel urdamycin O was found to be produced
in mutant 16-14 complemented with urdGT1c. Both new
urdamycins contain a second L-rhodinose unit in the trisac-
charide side chain. These compounds with the unusual
trisaccharide chain were previously observed neither in
the wt strain, nor in the Ax mutant or mutant 16-14.
Thus, UrdGT1c must be responsible for the linkage of
the terminal L-rhodinose moiety. Here it attaches its
NDP-sugar co-substrate to a foreign alcohol substrate at a
position which in the normal biosynthetic pathway is re-
served for a D-olivose moiety linked through UrdGT1b.
The result of this experiment again supports our assump-
tion that the speci¢city of a glycosyltransferase might be
regulated by a well-de¢ned control system in the cell.
Here, overexpression of the glycosyltransferase gene
urdGT1c leads to a relaxed speci¢city regarding its alcohol
substrate.
Relaxed speci¢city for both sugar co-substrates and alcohol
substrates (often just the aglycones) has been described
already for various glycosyltransferases [30^32]. Recently,
OleG2, a glycosyltransferase from S. antibioticus, which
transfers L-oleandrose in the wt strain, was shown to be
able to transfer L-rhamnose if expressed in a different
strain [32]. TylM2, a glycosyltransferase from S. fradiae,
was integrated into the chromosome of a triple mutant of
Saccharopolyspora erythraea. The resulting strain, fed with
tylactone, produced new hybrid antibiotics [33].
Despite all these results it is still dif¢cult to predict the
speci¢city of a given glycosyltransferase and it will need
more study to understand the parameters controlling the
function of these enzymes.
Signi¢cance
1. NDP-4-keto-2,6-dideoxy-D-glucose seems to be the
central intermediate in the biosynthesis of NDP-D-oli-
vose and NDP-L-rhodinose during urdamycin A biosyn-
thesis.
2. The speci¢city of two glycosyltransferases (UrdGT2,
UrdGT1c) of urdamycin biosynthesis is in£uenced by
the available concentration of the NDP-sugar co-sub-
strate as well as the expression level of the glycosyl-
transferase. While an over-concentration of the activated
sugar co-substrate can lead to a somewhat relaxed sugar
co-substrate speci¢city an overexpressed glycosyltrans-
ferase can overcome restrictions for its alcohol substrate.
Materials and methods
Bacterial strains, plasmids and culture conditions
For standard purposes, S. fradiae Tuë2717 [1] was grown on 1% malt
extract, 0.4% yeast extract, 0.4% glucose and 1 mM CaCl2, pH adjusted
to 7.2 (HA medium) at 28³C. DNA manipulation was carried out using
Escherichia coli XL-1 Blue MRFP (Stratagene) as host strain. Before
transforming S. fradiae Tuë2717, plasmids were propagated in E. coli
ET 12567 (dam3, dcm3, hsdS, CmR) [34] to obtain unmethylated
DNA. E. coli strains were routinely grown on Luria^Bertani (LB) agar
or liquid medium containing the appropriate antibiotic. pBluescript SK3
was from Stratagene and pLitmus 28 was from New England Biolabs.
Plasmid pKC1132, conferring apramycin resistance, was a kind gift of
Eli Lilly and Company. For gene expression experiments, plasmid
pUWL201 [4] and plasmid pEM4 [20] both conferring thiostrepton and
ampicillin resistance were used.
General genetic manipulation, DNA sequencing/sequence
analysis and PCR
Standard molecular biology procedures were performed as described
[35]. Isolation of E. coli plasmid DNA, DNA restriction, DNA modi¢cation
such as ¢lling-in sticky ends, and Southern hybridization were performed
following the protocols of the manufacturers of kits, enzymes and re-
agents (Amersham Pharmacia, Boehringer Mannheim, Promega, Stra-
tagene). Streptomyces protoplast formation, transformation, and proto-
plast regeneration were performed as described [36].
Nucleotide sequences were determined by the dideoxy chain termina-
tion method using automatic laser £uorescence sequencers (Molecular
Dynamics Vistra 725 or Perkin Elmer ABI). Sequencing reactions were
done using a thermosequenase cycle sequencing kit with 7-deaza-
dGTP (Amersham) and standard primers (M13 universal and reverse,
T3, T7). Computer-aided sequence analysis was done with the DNASIS
software package (version 2.1, 1995; Hitachi Software Engineering),
database searches were performed with the BLAST 2.0 program [37]
on the server of the National Center for Biotechnology Information, Be-
thesda, MD, USA. PCR was carried out using a Perkin Elmer GeneAmp
2400 thermal cycler. The conditions were as described [4] using oligo-
nucleotide primers listed in Table 1.
Construction of gene inactivation plasmids
urdQ: A unique NcoI restriction site inside the gene urdQ, which is
located at bases 287^292 on a 2.3 PstI fragment (fragment c in Figure
2) was chosen for targeted inactivation by shifting the reading frame.
After NcoI restriction, treatment with the Klenow fragment of E. coli DNA
polymerase I and religation, the intended alteration was checked by
DNA sequencing. The manipulated 2.3 kb PstI insert was then ligated
into the same site of pKC1132 to yield inactivation construct pKurdQpm.
For the construction of pKurdQifD, which would allow the introduction of
an in-frame deletion into urdQ, two fragments (urdQA and urdQB), con-
taining DNA that encodes aa 33^171 (urdQA) and aa 288^430 (urdQB)
of UrdQ, were ampli¢ed by PCR. Primers for the ampli¢cation of urdQA
were Q-1 and Q-3 and primers for the ampli¢cation of urdQB were Q-4
and Q-2. After restriction of fragment urdQA with EcoRI and BamHI, and
restriction of fragment urdQB with BglII and HindIII both fragments were
ligated into pKC1132 digested with EcoRI and HindIII to create pKurd-
QifD.
Table 1
Oligonucleotide primers used in PCR analyses of the different
urdamycin mutants of S. fradiae Tuë2717 and for PCR ampli¢-
cation of DNA fragments.
Name of primer Oligonucleotide sequence
S-1 5P-TGACCGGATCCACCCAGCCCCTCT-3P
S-2 5P-GTGAGCCGTCCGTCACCGCCCAAC-3P
Q-1 5P-GGAACCACCGAATTCTGGCCGTCC-3P
Q-2 5P-CTAGCCACAAGCTTCGACGAACTCCTTGAT-3P
Q-3 5P-GGCCATCTCGGATCCCTCGAACGG-3P
Q-4 5P-CGGTTACAGATCTAAGGCCACCGACATACAG-3P
Z1-1 5P-ACTGCACACGGTACCGGGCTGGAA-3P
Z1-2 5P-GCCGACGATGAATTCGGGACGCCA-3P
Z3-1 5P-GAAGAGCATCGAGCTCGGCGGGGACAG-3P
Z3-2 5P-ACCTCTTCCTGCAGCAGTTCCTTGCGG-3P
R-1 5P-ATGTGTCACTGCAGCACAGAGATCAGG
R-2 5P-TTCAGAAAGCATCAGAATTCTCCCGTG-3P
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urdR: The unique SplI site inside the urdR gene, which is located on a
2.3 kb PstI fragment (fragment c in Figure 2), was altered by SplI re-
striction and subsequent treatment as described for urdQ. Sequencing
of several plasmids revealed correct alteration (CGTACGTACG) along
one plasmid carrying an irregularly ¢lled SplI site (CGTGTACG).
Screening for double cross-over events by PCR requires the loss of
the restriction site used for introducing the frameshift. Correct ¢ll-in alters
the frame but recreates the SplI site making impossible a PCR-based
strategy for a double cross-over recognition. Therefore the plasmid with
the irregularly altered urdR gene was chosen for further work. Its 2.3 kb
PstI insert was then ligated into the PstI site of pKC1132 to create
inactivation plasmid pKCRN. For its integration into the chromosome
the inactivation construct provides 1.25 kb (upstream of the manipulated
SplI site) and 1.05 kb (downstream) £anking homologous DNA.
urdS: A 1.3 kb PstI fragment (fragment d in Figure 2) was restricted with
NcoI, treated with Klenow fragment and religated resulting in pKurdSpm.
For cross-over events there are 0.8 kb upstream and 0.5 kb downstream
of the altered NcoI site available. The intended alteration was checked
by DNA sequencing. pKurdSpm carries a frameshift mutation which
would create a fusion protein UrdS^UrdT containing 464 aa of UrdS.
urdZ1: A 1.4 kb section of fragment a (Figure 2) including the entire
reading frame of urdZ1 was ampli¢ed by PCR (fragment aP). Primers
were Z1-1 and Z1-2 which introduced restriction sites for BamHI and
EcoRI. This PCR fragment aP was cloned into pLitmus 28 to give
pLurdZ1. urdZ1 contains a unique SalI restriction site which is located
0.7 kb from either end of fragment aP. It was used for shifting the reading
frame by SalI restriction and subsequent end-¢lling using T4 DNA poly-
merase and religation. DNA sequencing con¢rmed correct ¢ll-in. The
Table 2
1H NMR data of the new urdamycins (N in ppm relative to TMS (J in Hz)).
Proton Urdamycin Ma Urdamycin Nb Urdamycin O
2-Ha ca. 3.00 (complex) 3.32 d (17) 2.85 (obsc. by water)
2-He 2.61 d, br (13) 3.20 dd (17; 2) 2.52 dd (13; 2)
3-CH3 1.22 s 1.46 s 1.13 s
4-Ha 2.33 d, br (15) 3.06 d (15) ca. 2.00 (complex)
4-He ca. 2.2 m 2.87 ddc (15; 2) 2.30 dd (15; 1)
5-H 6.95 d (10) 7.58 d (8) 6.48 d (10)
6-H 6.55 d (10) 7.95 d (8) 6.87 d (10)
10-H 8.06 d (8) 8.28 d (8) 7.95 d (8)
11-H 7.69 d (8) 7.74 d (8) 7.61 d (8)
1P-H 4.92 d, br (11) 4.92 dd (11; 1) 4.90 dd (11; 1)
2P-Ha ca. 1.1^1.8 (complex) 1.1^1.8 (complex) ca. 1.3 (complex)
2P-He ca. 1.1^1.8 (complex) 2.72 ddd (13; 5; 1) 2.70 ddd (13; 5; 1)
3P-H ca. 2.1 (complex) 4.00 ddd (12; 9; 4) 3.98 ddd (9; 9; 5)
4P-H 3.42 s, br 3.37 dd (9; 9) 3.36 dd (9; 9)
5P-H 3.85 q, br (6.5) 3.58 dq (9; 6) 3.60 dq (9, 6)
6P-H3 1.33 d (6.5) 1.37 d (6) 1.39 d (6)
1A-H ^ 5.02 d (2) 4.98 d (1)
2A-Ha ^ 1.1^1.8 (complex) ca. 2.0 (complex)
2A-He ^ 1.1^1.8 (complex) ca. 1.3 (complex)
3A-Ha ^ 1.1^1.8 (complex) ca. 1.6 (complex)
3A-He ^ 1.1^1.8 (complex) ca. 2.0 (complex)
4A-H ^ 3.50 s, br 3.52 s, br
5A-H ^ 4.23 q, br (6.5) 4.21 q, br (6.5)
6A-H3 ^ 1.15 d (6.5) 1.15 d (6.5)
1B-H ^ 5.17 d (2) 5.16 d (1)
2B-Ha ^ 1.1^1.8 (complex) 1.2^2.0 (complex)
2B-He ^ 1.1^1.8 (complex) 1.2^2.0 (complex)
3B-Ha ^ 1.1^1.8 (complex) 1.2^2.0 (complex)
3B-He ^ 1.1^1.8 (complex) 1.2^2.0 (complex)
4B-H ^ 3.53 s, br 3.53 s, br
5B-H ^ 4.34 q, br (6.5) 4.33 q, br (6.5)
6B-H3 ^ 1.09 d (6.5) 1.08 d (6.5)
1C-H 5.36 d (2) ^ 5.30 d (2)
2C-Ha 1.2^2.0 (complex) ^ 1.2^2.0 (complex)
2C-He 1.2^2.0 (complex) ^ 1.2^2.0 (complex)
3C-Ha 1.2^2.0 (complex) ^ 1.2^2.0 (complex)
3C-He 1.2^2.0 (complex) ^ 1.2^2.0 (complex)
4C-H 3.65 s, br ^ 3.32 s, br
5C-H 3.79 q, br (6.5) ^ 3.63 q, br (6.5)
6C-H3 0.58 d (6.5) ^ 0.49 d (6.5)
OH signals 3.36; 3.62; 4.45; 5.32; 12.4 ^d 3.33; 3.47; 3.55; 4.38; 5.32; 12.40
a500 MHz, d6-acetone.
b400 MHz, d6-acetone, assignment of the rhodinose signals (sugars A and B) is based on comparison with urdamycin B and urdamycin O,
and may be interchangeable.
cObscured by water, visible after addition of more D2O; br = broad signal.
dNot observed due to some D2O in the sample.
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altered insert of pLurdZ1 was then excised by BamHI and EcoRI re-
striction and inserted into pKC1132 to create the ¢nal inactivation plas-
mid pKC-urdZ1d.
urdZ3: The unique MroI site inside the urdZ3 gene, which is located at
bases 1114^1119 on a 2010 bp PstI fragment (fragment b in Figure 2)
was removed by restriction with this enzyme, end-blunting with T4 DNA
polymerase and religation therefore shifting the urdZ3 reading frame.
Correct ¢ll-in was checked by DNA sequencing. After religation the
2.0 kb PstI insert was ligated to the PstI site of pKC1132 to yield in-
activation plasmid pKCZ3.
Construction of gene complementation plasmids
urdQ, urdS, and urdZ1: A XbaI (BamHI) restriction site 5P to the ribo-
some binding site and an EcoRI restriction site 3P to the termination
codon were introduced by PCR into the genes urdQ and urdS (urdZ1)
using PCR. Fragments were cloned into the XbaI (BamHI) and EcoRI
site of pEM4.
urdR and urdZ3: The 2.0 kb PstI fragment (fragment b in Figure 2) was
cloned into the PstI site of pUWL201 to yield complementation construct
pUWL-Z3. Correct insert orientation was veri¢ed by DNA restriction.
Using a 2.3 kb PstI fragment (fragment c in Figure 2), the plasmid for
complementation of the urdR mutant (RN-435) was constructed identi-
cally as described for urdZ3.
Analysis of urdamycin A, its intermediates and new compounds
For urdamycin production S. fradiae Tuë2717 and all mutants mentioned
were grown in NL111V medium as described [4].
Cultures were extracted with an equal volume of ethyl acetate. After
evaporation of the solvent the dried extracts were redissolved in meth-
anol. TLC analysis was carried out on silica gel plates (silica gel 60
F254, Merck) with methylene chloride/methanol/ethyl acetate (8:1:1, v/v)
as solvent. Puri¢cation of crude extracts was carried out on Sephadex
LH-20 columns with methanol as solvent. Fractions containing new ur-
damycins were subjected to preparative HPLC as described [4].
Analytical HPLC-UV was performed on a Tosoh SC-8020 liquid chro-
matograph with a photodiode array detector and a Tosoh TSK-gel ODS-
80TM (150U4.6 mm) column maintained at 40³C. The detection wave-
length range was 250^500 nm. For elution the following gradient pro¢le
was used: solvent A: 0.5% AcOH in H2O, solvent B 0.5% AcOH in
CH3CN, non-linear gradient, 0^95% B within 30 min at a £ow rate of
0.8 ml/min. LC/MS was performed on a Thermoquest LCQ equipped
with Hewlett Packard HP1000 series LC under the identical conditions
described for HPLC, by atmospheric pressure chemical ionization
(APCI) and detection in the positive and negative mode. Urdamycin A
and its intermediates were identi¢ed by HPLC and mass spectrometry.
Production cultures of RN-435 yielded approximately 2 mg/l urdamycin
M, cultures of mutants Ax and 16-14, complemented with urdGT1c,
about 1.5 mg/l urdamycin N and urdamycin O, respectively.
Chemical analysis of urdamycinone B and other known
urdamycins
Urdamycinone B and all other known urdamycins were identical in TLC,
HPLC-UV/Vis, and HPLC-MS to those described earlier [1,3,4].
Structure determination of the new urdamycins M, N and O
All three new compounds were identi¢ed mainly by NMR spectroscopy,
the structures were also supported by mass spectrometry.
Urdamycin M: The 1H and 13C NMR data indicate two rhodinose moi-
eties as the sole sugar components of this new urdamycin derivative.
Typical are the 4-H (broad singlets, N 3.42 and N 3.65) and 5-H (broad
quartets, N 3.79 and N 3.85) signals, which are both due to the axial
4-OH position in rhodinose. The four carbon triplet signals around N 25
in the 13C NMR spectrum (see Tables 2 and 3) are signi¢cant for the
deoxygenated 2- and 3-positions. That one rhodinose unit is attached
Table 3
13C NMR data of urdamycin M (125.7 MHz) and O (100.6 MHz) in d6-acetone.
Carbon Urdamycin M Urdamycin O Carbon Urdamycin M Urdamycin O
1 202.6 s 202.5 s 4P 67.3 d 79.8 d
2 54.8 t 54.8 t 5P 77.2 d 77.0 d
3 76.2 s 76.2 s 6P 18.3 q 19.8 q
4 44.3 t 44.0 t 1A ^ 92.2 d
4a 82.7 s 81.8 s 2A ^ 23.5 ta
5 146.6 d 146.1 d 3A ^ 26.3 ta
6 117.4 d 117.2 d 4A ^ 76.1 db
6a 138.1 s 137.7 s 5A ^ 74.2 db
7 192.0 s 190.2 s 6A ^ 17.9 q
7a 114.9 s 115.0 s 1B ^ 98.1 d
8 158.0 s 157.8 s 2B ^ 23.3 ta
9 140.1 s 138.8 s 3B ^ 26.6 ta
10 134.8 d 134.1 d 4B ^ 67.0 db
11 120.1 d 120.1 d 5B ^ 68.1 db
11a 131.7 s 132.0 s 6B ^ 14.5 q
12 190.0 s 183.8 s 1C 95.2 d 95.0 d
12a 141.1 s 141.6 s 2C 23.4 ta 23.4 ta
12b 85.5 s 82.9 s 3C 26.4 ta 26.6 ta
13 30.6 q 30.0 q 4C 67.0 d 68.3 db
1P 74.3 d 72.0 d 5C 67.9 d 67.2 db
2P 24.0 ta 36.9 t 6C 16.9 q 17.0 q
3P 26.9 ta 68.0 d
Assignments and multiplicities from HMBC and HSQC spectra.
aAssignments interchangeable.
bAssignments interchangeable.
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at the 12b-position can be deduced from the signi¢cantly down¢eld
shifted 6-H3 signal (N 0.58) due to its location in the anisotropy cone
of the quinone chromophore. The 12b attachment is normal for an L-
rhodinose moiety, which here is also indicated by a small coupling
constant of the 1C-H signal (N 5.36). In contrast, the 1P-H signal
(N 4.92) appears as a broad doublet, with a large coupling constant of
11 Hz, which clearly indicates a L-glycosidically bound sugar, and
also a D-sugar, since both types of deoxysugars of the urdamycins,
D-olivose and L-rhodinose, are biosynthesized widely within the same
pathway. This determines that the activating NDP group is normally in
the axial position leading to L-attachment. It is only in the equatorial
position (for an K-attachment) after the 5-epimerase step, which per-
forms the D to L switch. The chemical shift of C-1P (N 74.3) clearly
indicates the C-glycosidic linkage. Urdamycin M has a molecular formu-
la C31H36O11 and a MW of 584.64, which has been con¢rmed by APCI-
MS (retention time: 18.08 min).
Urdamycin N: The 1H NMR data indicate two rhodinose (e.g., 4A-H and
4B-H appear as broad singlets, 5A-H and 5B-H as broad quartets) and
one olivose moiety along with an urdamycin B-type chromophore, which
follows from the two aromatic AB systems (N 7.58 and 7.95 and N 7.74
and 8.28, respectively). The D-olivose moiety is C-glycosidically linked,
as usually. The NMR data of the deoxysugar trisaccharide are identical
to the corresponding moiety in urdamycin O (see Table 2). The molec-
ular formula of urdamycin N, C37H44O12, MW 680.76, is con¢rmed by
the pos.-FAB MS of 681 (MH).
Urdamycin O: 1H and 13C NMR data (Tables 2 and 3) indicate three
L-rhodinose moieties. 4A-H, 4B-H and 4C-H appear as broad singlets
(N 3.52, 3.53, 3.32), 5A-H, 5B-H and 5C-H as broad quartets (N 4.21,
4.33, 3.63), respectively, and 1A-H, 1B-H and 1C-H (N 4.98, 5.16, 5.30)
show a small coupling constant, which proves their K-glycosidic linkage.
The corresponding C-1 carbons all show an O-glycosidic bondage (see
Table 3). A fourth sugar unit is the L-C-glycosidically connected D-oli-
vose, typical for many aquayamycin-type angucyclines. The sugar link-
ages are also proven by the HMBC data, which show 3JCÿH couplings
between 1P-H and C-9, 1A-H and C-3P, 3P-H and C-1A, 1B-H and C-4A,
4A-H and C-1B, and 1C-H and C-12b. The molecular formula of urda-
mycin O, C43H56O16, MW 828.92, is con¢rmed by the pos.-FAB MS
showing the largest signals at 829 (MH).
Diketopiperazines
The diketopiperazines cyclo-(phenylalanyl-4-hydroxy-prolyl), cyclo-(leuc-
yl-4-hydroxy-prolyl), and cyclo-(alanyl-4-hydroxy-prolyl) were identi¢ed
by their 1H and 13C NMR spectra, which were identical to those reported
in the literature.
Accession number
The sequence reported here has been deposited in the GenBank data
base under the accession numbers AF164961 and AF269227.
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